ViewRay Inc. (Nasdaq: VRAY) of Oakwood Village said it has signed an agreement with GenesisCare — a provider of cancer services in the United Kingdom, Spain and Australia — to bring the MRIdian MRI-guided radiotherapy system to the U.K. to benefit cancer patients.
Under the agreement, “multiple MRIdian linear accelerators will be deployed within the GenesisCare network, with the first two systems to be installed in the U.K.,” ViewRay said in a news release.
Click here to read the complete article.
Story excerpt provided by Crain’s Cleveland Business.
Originally published October 29, 2018.